Complications and serological tests of 10 patients with HTLV-I associated myelopathy (HAM)
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| Complications | ||||||||||
| recurrent uveitis | + | − | − | − | − | − | + | − | − | − |
| arthropathy | + | + | − | − | − | − | − | + | − | − |
| interstitial pneumonitis | − | − | + | − | − | − | − | − | − | − |
| Raynaud’s phenomenon | − | − | + | − | − | − | − | − | − | − |
| inflammatory bowel disease | − | − | − | − | − | − | + | − | − | − |
| Serological tests | ||||||||||
| ESR (mm/1h) | 55 | 18 | 164 | 15 | 4 | 48 | 10 | 37 | 12 | 37 |
| IgG (mg/d1, normal range; 972-2010) | 2634 | 1627 | 2690 | 1675 | 1625 | 4776 | 2400 | 2303 | 1649 | 2190 |
| IgA (mg/d1, normal range; 53-245) | 142 | 191 | 820 | 357 | 335 | 807 | 277 | 331 | 410 | 406 |
| IgM (mg/dl, normal range; male 53-245, female 67-359) | 189 | 124 | 197 | 307 | 184 | 321 | 105 | 195 | 116 | 262 |
| WBC (/mm3) | 4100 | 6600 | 2300 | 5400 | 3900 | 7300 | 5000 | 3300 | 5700 | 6200 |
| Atypical lymphocytes (%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |